Immuron Limited AI Stock Analysis
Immuron Limited (ANW) AI Stock Analysis
Immuron Limited
(Frankfurt:ANW)
No summary available
Immuron Limited (ANW) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 7.25M
- Dividend Yield
- ―
- Average Volume (3M)
- 8,854
- Price to Earnings (P/E)
- -2.9
- Beta (1Y)
- -0.43
- Revenue Growth
- 2.87%
- EPS Growth
- 46.27%
- Country
- Germany
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Immuron Limited Business Overview & Revenue Model
Company Description
Immuron Limited, an Australian biopharmaceutical firm founded in 1994 and headquartered in Carlton, is dedicated to the exploration, advancement, and worldwide commercialization of polyclonal antibodies. Operating across two divisions—Research and De...
Immuron Limited Risk Analysis
Immuron Limited disclosed 62 risk factors in its most recent earnings report. Immuron Limited reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
2 New RisksImmuron Limited Peers Comparison
Overall Rating
AU:BIO63Neutral
AU:AVE49Neutral
AU:ANR44Neutral
AU:EZZ42Neutral
AU:AGN40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | AUD 79.84M | 20.19 | 46.74% | ― | 29.68% | 1520.00% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | AUD 42.50M | -7.33 | -211.39% | ― | -46.59% | 9.09% | |
| 44Neutral | AUD 2.53M | -2.35 | -101.34% | ― | ― | 64.58% | |
| 42Neutral | AUD 13.64M | -2.56 | -20.36% | 13.76% | -30.79% | -177.68% | |
| 40Underperform | AUD 12.85M | -7.08 | -29.22% | ― | ― | 81.00% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:ANW | Immuron Limited | 0.02 | -0.01 | -38.46% | |
| AU:AVE | Avecho Biotechnology Limited | 0.01 | 0.00 | 10.00% | |
| AU:ANR | Anatara Lifesciences Ltd | 0.01 | 0.00 | 0.00% | |
| AU:AGN | Argenica Therapeutics Ltd | 0.10 | -0.13 | -55.56% | |
| AU:EZZ | EZZ Life Science Holdings Ltd. | 0.29 | -2.09 | -87.82% | |
| AU:BIO | Biome Australia Ltd | 0.34 | -0.07 | -15.85% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
